0,923  0,002  GST A substrate
0,885  0,002  Succinate dehydrogenase inhibitor
0,856  0,004  Eye irritation, high
0,812  0,003  Alcohol oxidase inhibitor
0,799  0,011  Caspase 9 stimulant
0,790  0,004  Platelet antagonist
0,766  0,004  CTGF expression inhibitor
0,765  0,004  Skin irritative effect
0,763  0,010  TNF expression inhibitor
0,735  0,003  Alpha-N-acetylglucosaminidase inhibitor
0,737  0,005  Cardiovascular analeptic
0,733  0,002  GABA C receptor agonist
0,725  0,002  GST P1-1 substrate
0,727  0,006  Cholesterol antagonist
0,717  0,004  Antimutagenic
0,718  0,007  Aldehyde oxidase inhibitor
0,700  0,002  Porphobilinogen synthase inhibitor
0,687  0,003  FMO1 substrate
0,693  0,016  Teratogen
0,679  0,004  Ulceration
0,671  0,008  Vasodilator, peripheral
0,664  0,007  NOS3 expression inhibitor
0,661  0,006  Histamine release inhibitor
0,671  0,017  Embryotoxic
0,662  0,009  5 Hydroxytryptamine release stimulant
0,655  0,006  Antipruritic, allergic
0,654  0,005  Antiseptic
0,658  0,016  CYP2C9 substrate
0,651  0,010  Atherosclerosis treatment
0,653  0,013  Antihypercholesterolemic
0,649  0,020  Antidiabetic
0,649  0,020  Cyclophilin D inhibitor
0,636  0,008  Lipoprotein disorders treatment
0,636  0,010  UGT1A9 substrate
0,626  0,008  5 Hydroxytryptamine release inhibitor
0,616  0,004  UGT2B1 substrate
0,622  0,012  Analeptic
0,614  0,004  Flavin-containing monooxygenase substrate
0,615  0,008  UGT1A6 substrate
0,618  0,013  Antiallergic
0,607  0,003  5 Hydroxytryptamine uptake stimulant
0,610  0,009  Apoptosis antagonist
0,612  0,014  Radioprotector
0,611  0,015  Antithrombotic
0,595  0,009  Antipyretic
0,590  0,005  Anesthetic general
0,602  0,017  Carcinogenic
0,588  0,004  Phospholipase C inhibitor
0,582  0,005  Platelet aggregation inhibitor
0,586  0,009  GABA C receptor rho-3 antagonist
0,579  0,003  Tyrosine 3 hydroxylase inhibitor
0,590  0,015  Bone diseases treatment
0,574  0,002  Ferrochelatase inhibitor
0,575  0,004  FMO3 substrate
0,572  0,004  UGT2B4 substrate
0,568  0,007  UGT1A4 substrate
0,577  0,017  Chemoprotective
0,572  0,016  Stroke treatment
0,575  0,020  Respiratory analeptic
0,557  0,004  Aldehyde dehydrogenase inhibitor
0,566  0,017  Sensitization
0,552  0,004  Glutathione S-transferase substrate
0,551  0,009  Hypolipemic
0,547  0,006  Peroxidase inhibitor
0,550  0,009  Superoxide dismutase inhibitor
0,541  0,002  Glutamate decarboxylase inhibitor
0,541  0,004  GST M1-1 substrate
0,537  0,005  Interleukin 2 agonist
0,543  0,015  Antiosteoporotic
0,547  0,020  CYP2C19 substrate
0,529  0,003  Antispirochetal
0,559  0,040  Antiarthritic
0,579  0,059  Antiinflammatory
0,527  0,009  Antidiabetic symptomatic
0,536  0,018  Immunomodulator
0,529  0,013  Hypoglycemic
0,519  0,005  Growth hormone agonist
0,520  0,008  Interleukin agonist
0,514  0,003  Glutamate dehydrogenase inhibitor
0,533  0,025  Immunosuppressant
0,507  0,004  Abortion inducer
0,512  0,010  Psychostimulant
0,504  0,002  Triose-phosphate isomerase inhibitor
0,513  0,013  Antiglaucomic
0,509  0,009  Antihypoxic
0,507  0,009  Myocardial infarction treatment
0,501  0,008  Antiulcerative
0,501  0,012  Angiogenesis stimulant
0,504  0,020  AR expression inhibitor
0,478  0,001  Aconitate hydratase inhibitor
0,482  0,008  UGT1A3 substrate
0,477  0,004  Antipruritic, non-allergic
0,488  0,018  Antidiabetic (type 2)
0,478  0,010  Radiosensitizer
0,490  0,024  Cardioprotectant
0,479  0,021  Antihypertensive
0,462  0,005  Acaricide
0,461  0,004  Carcinogenic, group 1
0,457  0,003  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,462  0,008  Antiparkinsonian, rigidity relieving
0,487  0,034  Toll-Like receptor agonist
0,454  0,003  Carbamoyl phosphate synthetase inhibitor
0,491  0,042  CYP3A4 substrate
0,456  0,007  UGT2B7 substrate
0,450  0,005  Insulin secretagoues
0,447  0,003  Phosphofructokinase-1 inhibitor
0,450  0,007  Sodium/bile acid cotransporter inhibitor
0,465  0,023  Interleukin antagonist
0,445  0,003  Catalase inhibitor
0,440  0,002  Adenylate kinase inhibitor
0,461  0,025  Cytostatic
0,435  0,002  Fumarate hydratase inhibitor
0,438  0,004  Antihyperlipoproteinemic
0,444  0,013  Wound healing agent
0,432  0,004  Gastrin inhibitor
0,431  0,010  Carcinogenic, group 3
0,445  0,025  NOS2 expression inhibitor
0,429  0,010  Hair growth stimulant
0,453  0,036  Immunostimulant
0,434  0,017  UDP-glucuronosyltransferase substrate
0,423  0,007  Protein kinase stimulant
0,442  0,026  Mutagenic
0,423  0,008  VCAM1 expression inhibitor
0,443  0,030  Antiischemic
0,417  0,006  Pancreatic disorders treatment
0,436  0,024  Proliferative diseases treatment
0,421  0,009  Thrombolytic
0,416  0,005  Cell adhesion inhibitor
0,436  0,027  ICAM1 expression inhibitor
0,426  0,019  Antihypertriglyceridemic
0,411  0,005  CNS active muscle relaxant
0,424  0,019  DNA synthesis inhibitor
0,424  0,019  Vasodilator
0,408  0,004  Alcohol dehydrogenase inhibitor
0,436  0,034  Hepatic disorders treatment
0,403  0,003  Photosensitizer
0,403  0,004  Excitatory amino acid transporter EAAC1 inhibitor
0,398  0,004  Prostaglandin EP2 antagonist
0,428  0,034  CYP1A2 substrate
0,412  0,024  Cardiodepressant
0,396  0,010  Skeletal muscle relaxant
0,402  0,017  UGT1A1 substrate
0,393  0,009  Lipocortins synthesis antagonist
0,390  0,006  DNA polymerase I inhibitor
0,390  0,008  Antidote
0,385  0,005  Phospholipase A2 inhibitor
0,390  0,010  Antineoplastic antimetabolite
0,393  0,014  Non-steroidal antiinflammatory agent
0,378  0,004  Prostaglandin antagonist
0,377  0,004  Coagulant
0,381  0,007  Insulin sensitizer
0,396  0,023  Acute neurologic disorders treatment
0,389  0,016  Muscle relaxant
0,423  0,051  Toll-Like receptor 7 agonist
0,373  0,004  GABA C receptor antagonist
0,389  0,023  Vascular (periferal) disease treatment
0,371  0,005  SULT1A3 substrate
0,366  0,003  UGT2B10 substrate
0,372  0,008  Antidiabetic (type 1)
0,375  0,015  Platelet adhesion inhibitor
0,384  0,025  Insulysin inhibitor
0,378  0,019  Septic shock treatment
0,396  0,037  Vasodilator, coronary
0,361  0,003  Argininosuccinate synthase inhibitor
0,359  0,003  SULT1A1 substrate
0,394  0,041  Spasmolytic
0,362  0,012  Bone formation stimulant
0,362  0,013  Interferon gamma antagonist
0,393  0,045  CYP2D6 substrate
0,352  0,004  Alcohol dehydrogenase substrate
0,369  0,022  RNA-directed DNA polymerase inhibitor
0,351  0,009  Antihelmintic (Nematodes)
0,402  0,063  Transcription factor NF kappa B inhibitor
0,349  0,011  Antiparkinsonian, tremor relieving
0,383  0,046  Antipsoriatic
0,349  0,013  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,384  0,050  Antifungal
0,336  0,005  Antineoplastic, alkylator
0,333  0,002  Glutamate (mGluR6) antagonist
0,344  0,016  Antiacne
0,330  0,003  Sphingosine 1-phosphate receptor 5 agonist
0,331  0,005  Antieczematic
0,351  0,025  Sedative
0,365  0,041  Calcium channel activator
0,400  0,077  Antibacterial
0,340  0,020  Antihypotensive
0,322  0,003  GST T1-1 substrate
0,360  0,041  Cytotoxic
0,323  0,005  Catenin beta inhibitor
0,330  0,012  CYP2B6 inhibitor
0,321  0,004  Toll-Like receptor 2 antagonist
0,322  0,005  Cell adhesion molecule inhibitor
0,330  0,014  Allergic rhinitis treatment
0,332  0,018  Diabetic retinopathy treatment
0,325  0,012  Corneal wound healing stimulator
0,318  0,005  Arylamine N-Acetyltransferase substrate
0,359  0,048  Lipoxygenase inhibitor
0,319  0,008  UGT2B9 substrate
0,313  0,004  Electrolyte absorption antagonist
0,333  0,023  Dual specificity phosphatase inhibitor
0,324  0,015  Protein-tyrosine phosphatase inhibitor
0,318  0,010  Cholesterol synthesis inhibitor
0,354  0,045  Antioxidant
0,325  0,018  Pneumotoxic
0,414  0,107  Apoptosis agonist
0,309  0,003  Prolactin inhibitor
0,375  0,071  Antiasthmatic
0,307  0,005  Peroxisome proliferator-activated receptor gamma agonist
0,303  0,004  Creatine kinase inhibitor
0,399  0,102  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,311  0,015  Neurotrophic factor enhancer
0,305  0,012  Renal failure treatment
0,295  0,003  Antirickettsial
0,295  0,004  Ornithine carbamoyltransferase inhibitor
0,309  0,018  Prostate disorders treatment
0,324  0,033  Cyclic AMP phosphodiesterase inhibitor
0,297  0,007  Uterine stimulant
0,312  0,022  DNA methyltransferase I inhibitor
0,294  0,004  Aldehyde dehydrogenase substrate
0,310  0,021  Diuretic
0,334  0,046  DNA damaging
0,291  0,004  Raynaud's phenomenon treatment
0,288  0,002  Antiviral (Parainfluenza)
0,330  0,045  Renal disease treatment
0,288  0,004  GABA C receptor rho-1 antagonist
0,288  0,003  Biliverdin reductase inhibitor
0,289  0,005  Choleretic
0,287  0,004  NAT1 substrate
0,300  0,018  Muscular dystrophy treatment
0,309  0,027  Hepatoprotectant
0,291  0,010  Antiviral (West Nile virus)
0,320  0,039  Chemopreventive
0,301  0,021  Anesthetic
0,302  0,022  Melanin inhibitor
0,302  0,023  Antialcoholic
0,296  0,019  Amylase inhibitor
0,286  0,009  Aminopeptidase B inhibitor
0,284  0,009  Antiviral (Poxvirus)
0,284  0,010  Antianemic
0,278  0,004  Folate antagonist
0,312  0,039  Antineoplastic (lymphocytic leukemia)
0,277  0,004  GABA aminotransferase inhibitor
0,279  0,007  Carbonic anhydrase III inhibitor
0,311  0,040  Antiparasitic
0,273  0,003  Adenylate cyclase stimulant
0,320  0,053  Antineoplastic (endocrine cancer)
0,277  0,010  Expectorant
0,286  0,019  UGT2B15 substrate
0,269  0,003  Arachidonic acid antagonist
0,295  0,030  Dual specificity phosphatase 3 inhibitor
0,275  0,012  Cell wall synthesis inhibitor
0,293  0,030  DNA methylase inhibitor
0,275  0,013  Antifungal enhancer
0,265  0,003  Sphingosine 1-phosphate receptor 4 agonist
0,266  0,004  Sphingosine 1-phosphate receptor 2 antagonist
0,284  0,023  Restenosis treatment
0,273  0,012  Cystathionine beta-synthase inhibitor
0,265  0,004  Phenylalanine 4-hydroxylase inhibitor
0,262  0,003  Glycine receptor agonist
0,266  0,008  Antifungal (Cryptococcus)
0,263  0,005  Integrin antagonist
0,262  0,005  Vanilloid 1 agonist
0,282  0,025  Antianorexic
0,258  0,003  Acyl-CoA dehydrogenase inhibitor
0,259  0,004  Plasminogen activator inhibitor antagonist
0,254  0,003  Lysophosphatidic acid 2 receptor antagonist
0,268  0,018  Neurotensin receptor agonist
0,272  0,023  Antiischemic, cerebral
0,254  0,004  Interferon agonist
0,251  0,004  Ornithine decarboxylase inhibitor
0,281  0,036  Antihelmintic
0,268  0,024  Lipid peroxidase inhibitor
0,249  0,005  Actinic keratosis treatment
0,250  0,006  Mucolytic
0,255  0,011  GABA C receptor rho-2 antagonist
0,252  0,009  Histidine decarboxylase inhibitor
0,246  0,005  TRPA1 agonist
0,254  0,013  Interleukin 4 antagonist
0,268  0,027  Sepsis treatment
0,294  0,053  Free radical scavenger
0,242  0,001  Glucose-6-phosphate isomerase inhibitor
0,244  0,004  NMDA receptor agonist
0,254  0,016  Protein-tyrosine phosphatase 1B inhibitor
0,240  0,003  Prostaglandin F2 alpha antagonist
0,255  0,019  Aldehyde oxidase substrate
0,238  0,002  Ca2+-transporting ATPase inhibitor
0,246  0,010  Antischistosomal
0,257  0,022  Interleukin 6 antagonist
0,237  0,004  Antidote, mercury
0,249  0,017  Alkylator
0,248  0,017  Aldose reductase substrate
0,235  0,004  Sphingosine 1-phosphate receptor 5 antagonist
0,238  0,007  NAT2 substrate
0,233  0,004  Restless leg syndrome treatment
0,242  0,015  Antiviral (Ebola)
0,274  0,048  Anticonvulsant
0,240  0,013  Cathepsin G inhibitor
0,248  0,023  Genotoxic
0,249  0,024  Monophenol monooxygenase inhibitor
0,228  0,005  Sphingosine 1-phosphate receptor 4 antagonist
0,228  0,006  Thioredoxin inhibitor
0,242  0,020  Pulmonary hypertension treatment
0,231  0,011  Mediator release inhibitor
0,223  0,004  Antidote, heavy metal
0,232  0,013  Retinoprotector
0,244  0,026  Antipruritic
0,224  0,006  Myasthenia Gravis treatment
0,225  0,009  NADH dehydrogenase inhibitor
0,230  0,016  Cathepsin H inhibitor
0,259  0,045  Peptidyltransferase inhibitor
0,223  0,010  Growth stimulant
0,225  0,012  Cyclooxygenase 3 inhibitor
0,239  0,027  Age-related macular degeneration treatment
0,215  0,003  UGT2B11 substrate
0,227  0,015  UDP-glucose 4-epimerase inhibitor
0,215  0,003  Antifungal (Pneumocystis)
0,215  0,003  GABA B receptor agonist
0,216  0,005  Leukotriene synthesis inhibitor
0,258  0,049  Neuropeptide Y2 antagonist
0,215  0,007  Caspase 3 inhibitor
0,215  0,007  Keratolytic
0,232  0,024  Hemostatic
0,245  0,040  Anticoagulant
0,228  0,023  Antiprotozoal (Coccidial)
0,209  0,006  Aminopeptidase I inhibitor
0,297  0,095  Thyroid hormone antagonist
0,206  0,003  Glutamate (mGluR3) antagonist
0,221  0,021  Chelator
0,207  0,006  CDC25A inhibitor
0,207  0,007  Toll-Like receptor 2 agonist
0,217  0,017  Farnesoid X receptor antagonist
0,211  0,012  Contraceptive female
0,207  0,009  Antiviral (Influenza B)
0,317  0,120  15-Lipoxygenase inhibitor
0,202  0,005  Glutathione S-transferase inhibitor
0,225  0,028  VEGF expression inhibitor
0,228  0,033  Liver fibrosis treatment
0,197  0,003  Prostaglandin agonist
0,200  0,007  Vanilloid agonist
0,198  0,005  Paget's disease treatment
0,204  0,011  Selectin antagonist
0,196  0,004  Glycine receptor antagonist
0,196  0,004  Anticholelithogenic
0,198  0,006  Leukotriene antagonist
0,195  0,005  Glutamate release inhibitor
0,197  0,007  GP IIb/IIIa receptor antagonist
0,230  0,042  Prostatic (benign) hyperplasia treatment
0,211  0,023  Gout treatment
0,308  0,119  CYP2C19 inhibitor
0,214  0,027  ATPase inhibitor
0,204  0,017  Sulfotransferase substrate
0,209  0,023  5-Lipoxygenase inhibitor
0,195  0,010  Hematopoietic
0,204  0,020  Shock treatment
0,191  0,008  Toll-Like receptor 4 antagonist
0,203  0,021  Carcinogenic, group 2B
0,200  0,018  Movement disorders treatment
0,196  0,014  Interleukin 8 antagonist
0,229  0,047  Antianginal
0,230  0,049  Nitric-oxide synthase stimulant
0,193  0,013  HIV-1 integrase (Overall Integration) inhibitor
0,194  0,014  Carbonic anhydrase VI inhibitor
0,187  0,008  Interleukin 1 beta converting enzyme inhibitor
0,187  0,009  Heat shock protein 70 antagonist
0,195  0,019  Anticataract
0,271  0,095  Caspase 3 stimulant
0,182  0,006  Glycine transporter 2 inhibitor
0,182  0,007  Anabolic
0,201  0,025  Adenylate cyclase inhibitor
0,184  0,009  DOPA decarboxylase inhibitor
0,179  0,005  Lanosterol 14 alpha demethylase inhibitor
0,202  0,029  Histone deacetylase SIRT1 inhibitor
0,177  0,004  Purinergic P2Y12 antagonist
0,208  0,036  Thiol protease inhibitor
0,209  0,037  Acute respiratory distress syndrome (ARDS) treatment
0,187  0,016  Carbonic anhydrase XIII inhibitor
0,218  0,047  Antiviral (Hepatitis)
0,242  0,073  Calpain inhibitor
0,171  0,002  Lysophosphatidic acid 3 receptor antagonist
0,202  0,034  Phobic disorders treatment
0,204  0,036  Antineoplastic (bone cancer)
0,260  0,092  Antiepileptic
0,205  0,039  Antiviral (Hepatitis C)
0,178  0,013  Antiviral (Papilloma)
0,168  0,004  AMPA 4 receptor antagonist
0,191  0,027  Rhinitis treatment
0,166  0,003  ATP citrate lysase inhibitor
0,194  0,030  Neurotrophic factor
0,166  0,004  Mannosidase inhibitor
0,177  0,015  Sphingomyelinase inhibitor
0,185  0,024  Microtubule formation inhibitor
0,166  0,005  Bile acid receptor antagonist
0,267  0,107  Thyroid hormone beta antagonist
0,260  0,103  12-Lipoxygenase inhibitor
0,161  0,004  Interferon inducer
0,162  0,005  Sphingosine 1-phosphate receptor antagonist
0,169  0,013  Electron transport complex I inhibitor
0,180  0,024  Nav1.4 sodium channel blocker
0,160  0,005  SULT1A2 substrate
0,160  0,004  Thromboxane synthase inhibitor
0,159  0,004  Leukotriene D4 antagonist
0,281  0,127  Calpain 2 inhibitor
0,157  0,005  Leukotriene B4 antagonist
0,181  0,029  Antiprotozoal (Trichomonas)
0,171  0,020  Antihelmintic (Fasciola)
0,196  0,045  Neuropathy treatment
0,154  0,004  Sphingosine 1-phosphate receptor 1 antagonist
0,177  0,027  Antihelmintic (Trematoda)
0,163  0,014  ABCA1 expression enhancer
0,153  0,004  Thromboxane antagonist
0,160  0,011  Antimetabolite
0,156  0,008  Tourette's syndrome treatment
0,158  0,010  Antileprosy
0,167  0,020  Gastric antisecretory
0,158  0,010  Carbonic anhydrase stimulant
0,152  0,005  Peroxisome proliferator-activated receptor delta antagonist
0,194  0,047  Toxic, respiratory center
0,213  0,067  Antiviral (Influenza)
0,175  0,030  Antibacterial (Helicobacter pylori)
0,151  0,007  Purinergic P2X1 antagonist
0,181  0,037  Anesthetic local
0,147  0,003  Leukotriene B4 receptor 1 antagonist
0,150  0,006  CDC25B inhibitor
0,148  0,005  Endocannabinoid uptake inhibitor
0,147  0,004  Prostaglandin D2 antagonist
0,193  0,050  Urolithiasis treatment
0,147  0,006  Peroxisome proliferator-activated receptor alpha agonist
0,161  0,020  Uric acid excretion stimulant
0,178  0,038  CF transmembrane conductance regulator agonist
0,144  0,003  Prostaglandin E2 agonist
0,151  0,011  Antifungal (Candida)
0,143  0,004  Phospholipase D inhibitor
0,170  0,031  Histone deacetylase class III inhibitor
0,146  0,008  Hyperparathyroidism treatment
0,142  0,003  Anesthetic inhalation
0,141  0,002  Membrane dipeptidase inhibitor
0,145  0,007  5-Alpha-reductase inhibitor
0,142  0,004  Alpha-mannosidase inhibitor
0,141  0,004  Vanilloid 4 agonist
0,198  0,062  Antieczematic atopic
0,141  0,004  Thromboxane A2 antagonist
0,152  0,015  Transcription factor NF kappa B stimulant
0,166  0,030  Pregnane X receptor agonist
0,141  0,005  Cholecystokinin B agonist
0,160  0,025  HDL-cholesterol increasing
0,233  0,098  Transcription factor STAT3 inhibitor
0,177  0,043  Skin whitener
0,141  0,007  Caspase 9 inhibitor
0,137  0,003  Prostacyclin agonist
0,141  0,007  Narcotic antagonist
0,222  0,089  Heart failure treatment
0,138  0,005  Purinergic P2Y antagonist
0,146  0,014  Interleukin 12 antagonist
0,181  0,048  Hexokinase inhibitor
0,137  0,005  Estrogen-related receptor beta agonist
0,149  0,017  Acetylcholine release stimulant
0,261  0,131  Inflammatory Bowel disease treatment
0,134  0,004  Kainate receptor 2 antagonist
0,133  0,003  Glutamate (mGluR1a) agonist
0,175  0,046  Mannose-6-phosphate isomerase inhibitor
0,160  0,031  Xanthine oxidase inhibitor
0,133  0,004  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,137  0,009  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,132  0,004  Sphingosine 1-phosphate receptor agonist
0,148  0,021  Antiprotozoal (Toxoplasma)
0,136  0,009  Granulocyte macrophage colony stimulating factor agonist
0,128  0,003  Prostaglandin EP4 agonist
0,128  0,002  Kainate receptor agonist
0,189  0,066  Diabetic nephropathy treatment
0,151  0,028  AMP-activated protein kinase stimulant
0,214  0,091  Antiamyloidogenic
0,127  0,004  Prostacyclin antagonist
0,127  0,005  Sphingosine 1-phosphate receptor 3 antagonist
0,128  0,007  NMDA receptor glycine site agonist
0,126  0,004  Glutamate (mGluR7) antagonist
0,126  0,004  Glutamate (mGluR4) antagonist
0,155  0,035  Menstruation disorders treatment
0,189  0,069  Myocardial ischemia treatment
0,125  0,005  Kainate receptor antagonist
0,123  0,003  Leukotriene C antagonist
0,127  0,008  NMDA receptor subunit 3B antagonist
0,133  0,014  Ribonucleoside-diphosphate reductase inhibitor
0,122  0,003  Glutamate (mGluR1) agonist
0,125  0,007  CD45 antagonist
0,128  0,010  Elastase 1 inhibitor
0,122  0,004  Retinoid X alpha receptor agonist
0,123  0,005  Gaucher disease treatment
0,176  0,059  Cystic fibrosis treatment
0,118  0,003  Calcium-dependent phospholipase A2 inhibitor
0,119  0,004  Free fatty acid receptor 1 agonist
0,118  0,002  Glutamate (mGluR8) agonist
0,130  0,015  Ribonucleotide reductase inhibitor
0,123  0,009  Peroxisome proliferator-activated receptor gamma antagonist
0,119  0,005  Antidote, organophosphates
0,118  0,005  Prostaglandin EP3 antagonist
0,117  0,004  SULT2A1 substrate
0,118  0,005  Leukotriene A4 hydrolase inhibitor
0,223  0,110  Antineurogenic pain
0,162  0,049  Hearing loss treatment
0,167  0,055  Antidiarrheal
0,117  0,005  5-Alpha-reductase 2 inhibitor
0,117  0,005  Glutamate (mGluR group III) antagonist
0,119  0,007  Macrophage elastase inhibitor
0,115  0,004  Prostaglandin EP4 antagonist
0,121  0,011  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,118  0,008  Antimycoplasmal
0,184  0,074  Nitric oxide antagonist
0,154  0,044  Proteasome inhibitor
0,114  0,004  Sphingosine 1-phosphate receptor 1 agonist
0,128  0,019  Tocolytic
0,110  0,001  Carbonic anhydrase X inhibitor
0,110  0,001  Carbonic anhydrase VIII inhibitor
0,112  0,003  Arginase inhibitor
0,130  0,022  Glutamate (mGluR7) agonist
0,112  0,005  MDM2 inhibitor
0,120  0,012  Carbonic anhydrase VB inhibitor
0,111  0,004  Retinoid X receptor agonist
0,118  0,011  NMDA 2C receptor antagonist
0,219  0,113  Transcription factor STAT inhibitor
0,117  0,012  Prostaglandin E2 antagonist
0,144  0,039  Falcipain 3 inhibitor
0,124  0,020  Carbonic anhydrase V inhibitor
0,108  0,004  Glucagon receptor antagonist
0,106  0,003  Prostaglandin EP2 agonist
0,178  0,075  LDLR expression enhancer
0,143  0,040  GABA receptor agonist
0,106  0,003  N-Acetylated alpha-linked acidic dipeptidase inhibitor
0,131  0,029  Calcium antagonist
0,197  0,096  Antiviral (HIV)
0,227  0,125  Metabolic disease treatment
0,117  0,016  Caspase 7 inhibitor
0,130  0,029  Posttraumatic stress disorder treatment
0,105  0,005  Integrin alpha4 antagonist
0,113  0,013  Antiemphysemic
0,163  0,064  Antiviral (Influenza A)
0,102  0,003  Prostaglandin D2 agonist
0,101  0,002  Lysophosphatidic acid receptor 1 agonist
0,103  0,005  Glucagon-like peptide 1 receptor antagonist
0,116  0,019  Na+ K+ transporting ATPase inhibitor
0,147  0,049  Antihemorrhagic
0,117  0,019  Carbonic anhydrase VA inhibitor
0,102  0,005  GABA B receptor antagonist
0,103  0,005  Peroxisome proliferator-activated receptor delta agonist
0,100  0,004  Thyroid hormone alpha antagonist
0,113  0,018  D-Ala-D-Ala ligase inhibitor
0,099  0,004  Lysine carboxypeptidase inhibitor
0,098  0,004  Pregnane X receptor antagonist
0,120  0,025  Macrophage migration inhibitory factor inhibitor
0,098  0,003  Sodium-dependent vitamin C transporter 2 inhibitor
0,130  0,036  Chronic obstructive bronchitis treatment
0,132  0,038  Carbonic anhydrase XV inhibitor
0,130  0,036  Potassium channel (Ca-activated) activator
0,099  0,005  Purinergic P2T antagonist
0,111  0,017  Glucagon-like peptide 1 agonist
0,101  0,007  Sphingosine kinase inhibitor
0,138  0,044  DNA repair enzyme inhibitor
0,097  0,004  Ryanodine receptor antagonist
0,096  0,003  Leukotriene C4 antagonist
0,096  0,005  5-Alpha-reductase 1 inhibitor
0,099  0,008  Cholecystokinin antagonist
0,117  0,026  Inducible nitric-oxide synthase inhibitor
0,148  0,057  Nav1.6 sodium channel blocker
0,117  0,026  Interleukin 5 antagonist
0,120  0,029  Metalloproteinase-2 inhibitor
0,091  0,002  Prostaglandin F2 alpha agonist
0,157  0,068  Acetylcholine M1 receptor antagonist
0,093  0,004  AMPA 3 receptor antagonist
0,104  0,015  Maillard reaction inhibitor
0,092  0,004  Geranyltranstransferase inhibitor
0,093  0,005  AICAR transformylase inhibitor
0,122  0,034  Carcinogenic, group 2A
0,102  0,014  Antitreponemal
0,271  0,184  Calcium channel L-type activator
0,108  0,021  Epoxide hydrolase inhibitor
0,096  0,009  NMDA receptor subunit 3A antagonist
0,131  0,045  Antiviral (CMV)
0,196  0,110  Antineoplastic (liver cancer)
0,092  0,007  Adenosine deaminase inhibitor
0,103  0,017  Aldose reductase inhibitor
0,116  0,031  Antiviral (Rhinovirus)
0,090  0,005  Nicotinic acid receptor agonist
0,096  0,011  Antiviral (Herpesvirus 3, Human)
0,088  0,004  GABA transporter 3 inhibitor
0,122  0,037  Factor V inhibitor
0,087  0,004  Kainate receptor 1 antagonist
0,142  0,059  Cocaine dependence treatment
0,088  0,005  Thymidylate synthase inhibitor
0,245  0,162  Antiobesity
0,089  0,006  AMPA 1 receptor antagonist
0,086  0,004  GABA uptake inhibitor
0,177  0,095  Pyruvate kinase inhibitor
0,082  0,002  Lysophosphatidic acid receptor 3 agonist
0,103  0,023  Amidase inhibitor
0,134  0,053  Beta amyloid protein antagonist
0,097  0,017  Neuraminidase inhibitor
0,083  0,003  Glutamate (mGluR3) agonist
0,086  0,007  Urate transporter 1 inhibitor
0,090  0,010  Diacylglycerol O-acyltransferase inhibitor
0,083  0,004  Free fatty acid receptor 1 antagonist
0,084  0,005  Vitronectin receptor antagonist
0,092  0,013  Carbonic anhydrase XIV inhibitor
0,143  0,064  Psychosexual dysfunction treatment
0,087  0,008  Sphingosine 1-phosphate receptor 3 agonist
0,096  0,017  Neuraminidase (influenza) inhibitor
0,112  0,033  ErbB-3 antagonist
0,141  0,062  Toll-Like receptor antagonist
0,103  0,024  Antiviral (Dengue virus)
0,079  0,002  Thromboxane agonist
0,088  0,011  Cholecystokinin A antagonist
0,093  0,016  Acetyl-CoA transferase inhibitor
0,110  0,033  NAD(P)H dehydrogenase (quinone) inhibitor
0,111  0,035  Phosphodiesterase 6D inhibitor
0,080  0,004  Glutamate (mGluR8) antagonist
0,084  0,008  Adenine nucleotide translocase inhibitor
0,084  0,008  Phosphoglycerate kinase inhibitor
0,091  0,016  NMDA 2A receptor antagonist
0,090  0,015  Exportin-1 inhibitor
0,089  0,014  Hypercalcemia treatment
0,087  0,012  Corticotropin releasing factor 2 receptor antagonist
0,113  0,039  NMDA receptor antagonist
0,077  0,003  G-protein-coupled receptor 120 agonist
0,200  0,126  Antineoplastic (sarcoma)
0,077  0,003  Retinoid X receptor antagonist
0,120  0,047  Mental retardation treatment
0,100  0,027  Prostaglandin-E synthase inhibitor
0,100  0,027  Lipase inhibitor
0,150  0,078  Antiviral (Herpes)
0,112  0,041  Antineoplastic alkaloid
0,076  0,005  Peroxisome proliferator-activated receptor alpha antagonist
0,087  0,016  Nitric oxide donor
0,084  0,013  Sphingosine kinase 2 inhibitor
0,078  0,007  Heparanase inhibitor
0,090  0,020  Protease 3C (Human rhinovirus) inhibitor
0,075  0,005  Peptide deformylase inhibitor
0,135  0,066  NADPH oxidase inhibitor
0,080  0,011  HCV NS3/NS4A protease inhibitor
0,071  0,003  Lysophosphatidic acid 1 receptor antagonist
0,082  0,014  Glucosylceramidase inhibitor
0,088  0,020  Uterine relaxant
0,079  0,011  Acetyl-CoA transferase 2 inhibitor
0,093  0,025  Neutrophil collagenase inhibitor
0,138  0,071  Contraceptive
0,080  0,013  Lipocortins synthesis agonist
0,075  0,008  VLA-4 antagonist
0,079  0,013  Leukocyte elastase inhibitor
0,101  0,034  Antibiotic
0,071  0,005  Guanylate cyclase inhibitor
0,073  0,007  Caspase 2 inhibitor
0,126  0,060  Antitussive
0,073  0,008  AMPA 2 receptor antagonist
0,069  0,005  Kynurenine 3 monooxygenase inhibitor
0,069  0,005  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,100  0,036  Chymotrypsin inhibitor
0,085  0,020  Beta 3 adrenoreceptor antagonist
0,072  0,008  Dihydropteroate synthase inhibitor
0,110  0,046  Nitric-oxide synthase inhibitor
0,114  0,052  Antiinfertility, female
0,067  0,004  Retinoid X gamma receptor agonist
0,067  0,005  Integrin beta3 antagonist
0,127  0,065  Gastritis treatment
0,066  0,004  Excitatory amino acid transporter 2 inhibitor
0,071  0,009  Squalene synthetase inhibitor
0,119  0,058  Estrogen antagonist
0,069  0,008  Cytokine production stimulant
0,062  0,002  Thromboxane A2 agonist
0,065  0,005  VCAM-1 antagonist
0,065  0,005  VCAM antagonist
0,069  0,009  Dopamine D5 agonist
0,076  0,016  Angiotensin-converting enzyme inhibitor
0,064  0,003  Retinoid X alpha receptor antagonist
0,082  0,023  Androgen agonist
0,063  0,003  Ileal bile acid transport inhibitor
0,064  0,005  Angiotensin AT1 receptor antagonist
0,064  0,004  Integrin alphaVbeta3 antagonist
0,074  0,014  DNA helicase inhibitor
0,086  0,027  S-adenosyl-L-methionine decarboxylase inhibitor
0,063  0,004  Angiotensin II receptor antagonist
0,083  0,025  Beta adrenoreceptor antagonist
0,120  0,062  Constipation treatment
0,078  0,021  Matrix metalloproteinase (membrane-type) inhibitor
0,062  0,005  Uridine phosphorylase inhibitor
0,075  0,018  Bombesin 2 receptor antagonist
0,066  0,009  Neuraminidase (Influenza A) inhibitor
0,088  0,032  Matrix metalloproteinase inhibitor
0,070  0,014  Squalene epoxidase inhibitor
0,060  0,004  Thyroid hormone agonist
0,060  0,004  Epoxide hydrolase 1 inhibitor
0,069  0,013  Calcitonin receptor agonist
0,090  0,035  Estrogen receptor alpha antagonist
0,109  0,054  Antihypermotility
0,092  0,037  Metalloproteinase-9 inhibitor
0,075  0,021  Potassium channel intermediate-conductance Ca-activated blocker
0,057  0,002  Vanilloid 2 agonist
0,098  0,043  ATPase (Vacuolar H+) inhibitor
0,075  0,020  Autotaxin inhibitor
0,072  0,018  Metalloproteinase-3 inhibitor
0,203  0,148  Hypoxia-inducible factor 1 alpha inhibitor
0,096  0,042  Antiviral (Hepatitis A)
0,059  0,005  HMG CoA reductase inhibitor
0,059  0,005  Vanilloid 3 antagonist
0,058  0,005  Integrin alpha1beta1 antagonist
0,059  0,005  Kainate receptor 4 antagonist
0,057  0,003  Calcium-independent phospholipase A2 inhibitor
0,169  0,115  Histone acetyltransferase inhibitor
0,062  0,009  Dihydrofolate reductase inhibitor
0,075  0,022  Fatty acid synthase inhibitor
0,060  0,007  GABA transporter 2 inhibitor
0,061  0,009  p53 inhibitor
0,074  0,022  Beta 1 adrenoreceptor antagonist
0,056  0,004  Leukotriene B4 receptor 2 antagonist
0,084  0,032  Sirtuin 1 inhibitor
0,117  0,065  Transcription factor STAT6 inhibitor
0,061  0,009  Sphingosine kinase 1 inhibitor
0,054  0,002  Retinoid X beta receptor antagonist
0,060  0,009  Cholecystokinin B antagonist
0,067  0,016  Vanilloid 2 antagonist
0,071  0,020  Postcoital contraceptive
0,108  0,058  Urease inhibitor
0,067  0,017  Oleamide hydrolase inhibitor
0,093  0,042  Antiprotozoal activity enhancer
0,108  0,058  Protease inhibitor
0,053  0,003  Prostaglandin H2 antagonist
0,064  0,015  Fructose-1,6-bisphosphatase inhibitor
0,126  0,077  Nav1.2 sodium channel blocker
0,056  0,007  Liver X receptor beta antagonist
0,053  0,005  Retinoid X beta receptor agonist
0,123  0,075  M17 leucyl aminopeptidase inhibitor
0,097  0,049  Histamine N-methyltransferase inhibitor
0,097  0,049  Androgen antagonist
0,062  0,015  Oxytocin agonist
0,091  0,044  Glutamate receptor agonist
0,054  0,007  Cholecystokinin agonist
0,084  0,037  MAP kinase kinase 7 inhibitor
0,052  0,006  Carboxypeptidase B inhibitor
0,075  0,028  Collagenase 3 inhibitor
0,189  0,142  Amyotrophic lateral sclerosis treatment
0,055  0,009  Angiotensin AT2 receptor antagonist
0,062  0,016  Cholesterol esterase inhibitor
0,065  0,020  Beta 2 adrenoreceptor antagonist
0,062  0,017  Glutamate (mGluR group III) agonist
0,048  0,004  Nicotinic acid receptor 2 antagonist
0,049  0,005  Kainate receptor 5 antagonist
0,051  0,006  Ceramide glucosyltransferase inhibitor
0,060  0,016  Dihydroorotase inhibitor
0,117  0,074  Antiprotozoal (Amoeba)
0,046  0,002  Glutamate (mGluR6) agonist
0,095  0,051  Aminoacyl-tRNA synthetase inhibitor
0,051  0,008  Carnitine palmitoyltransferase inhibitor
0,087  0,044  CC chemokine 5 receptor agonist
0,057  0,014  G protein-coupled receptor agonist
0,172  0,129  5 Hydroxytryptamine 3E antagonist
0,063  0,020  Carbonic anhydrase II stimulant
0,056  0,014  Integrin alpha5beta1 antagonist
0,074  0,032  Cannabinoid CB1 receptor agonist
0,057  0,015  Thymidine kinase inhibitor
0,053  0,012  Retinoic acid alpha receptor agonist
0,053  0,013  Farnesoid X receptor agonist
0,050  0,010  Cholesterol absorption inhibitor
0,048  0,009  Carnitine palmitoyltransferase 1 inhibitor
0,044  0,005  Integrin alphaVbeta1 antagonist
0,044  0,005  Purinergic P2Y15 antagonist
0,048  0,009  Hypoxanthine phosphoribosyltransferase inhibitor
0,116  0,078  Nav1.3 sodium channel blocker
0,042  0,004  Hedgehog signaling activator
0,152  0,114  P-glycoprotein inhibitor
0,179  0,141  Cardiotonic
0,040  0,002  Carbonic anhydrase XI inhibitor
0,045  0,008  Methionyl aminopeptidase 1 inhibitor
0,043  0,007  Elastase 3A inhibitor
0,043  0,007  Elastase 3B inhibitor
0,043  0,007  Elastase 2B inhibitor
0,100  0,064  Bronchodilator
0,041  0,004  Aminopeptidase A inhibitor
0,059  0,022  Complement C3a chemotactic receptor antagonist
0,055  0,019  Erythropoietin receptor agonist
0,040  0,003  Excitatory amino acid transporter 3 inhibitor
0,084  0,048  Sleep apnea treatment
0,056  0,021  Adenylate cyclase 1 inhibitor
0,040  0,005  Retinoid X gamma receptor antagonist
0,055  0,021  Dopamine beta hydroxylase inhibitor
0,044  0,010  Tryptophan 5 hydroxylase inhibitor
0,059  0,026  Immunoglobulin Fc receptor antagonist
0,050  0,017  Acetyl-CoA transferase 1 inhibitor
0,037  0,004  Isoleucine-tRNA ligase inhibitor
0,036  0,004  Neuraminidase (Influenza B) inhibitor
0,067  0,034  Xanthine dehydrogenase inhibitor
0,059  0,026  Prolyl endopeptidase inhibitor
0,054  0,022  Carbonic anhydrase IV inhibitor
0,066  0,034  Aminopeptidase microsomal inhibitor
0,102  0,070  Antifungal (Aspergillus)
0,057  0,026  Endothelin-converting enzyme inhibitor
0,067  0,035  Calcium channel P-type blocker
0,068  0,037  HIV-1 integrase (Strand Transfer) inhibitor
0,059  0,028  Nicotinic alpha3beta2 receptor antagonist
0,053  0,022  Benzodiazepine antagonist
0,057  0,026  AMPA receptor antagonist
0,060  0,029  Dihydroorotate oxidase inhibitor
0,064  0,034  Beta 2 adrenoreceptor agonist
0,076  0,046  Potassium channel (Tandem pore domain) blocker
0,086  0,055  mTOR complex 2 inhibitor
0,042  0,012  Endothelin receptor antagonist
0,035  0,004  Apical sodium codependent bile acid transporter inhibitor
0,039  0,009  Caspase 6 inhibitor
0,034  0,004  Caspase 8 inhibitor
0,039  0,009  Neutral endopeptidase inhibitor
0,045  0,015  Integrin alpha2 antagonist
0,083  0,054  Thioredoxin reductase inhibitor
0,041  0,012  Diacylglycerol O-acyltransferase 1 inhibitor
0,102  0,073  Protein kinase C gamma inhibitor
0,049  0,021  Guanylate cyclase stimulant
0,069  0,041  Antihemophilic
0,076  0,048  Adenosine A3 receptor antagonist
0,032  0,004  Vitamin D receptor agonist
0,033  0,005  Kainate receptor 3 antagonist
0,042  0,014  Glutamate (mGluR4) agonist
0,081  0,053  Acetylcholine nicotinic antagonist
0,055  0,028  Phosphorylase inhibitor
0,033  0,007  GRP78 expression inhibitor
0,034  0,008  Toll-Like receptor 4 agonist
0,034  0,007  Integrin beta5 antagonist
0,058  0,032  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,140  0,114  Tumour necrosis factor antagonist
0,072  0,046  HIV-1 integrase inhibitor
0,029  0,003  Methylmalonyl-CoA mutase inhibitor
0,035  0,009  Prostaglandin EP1 antagonist
0,046  0,020  Heme oxygenase inhibitor
0,030  0,005  Retinoic acid beta receptor agonist
0,044  0,019  MAP3K5 inhibitor
0,030  0,005  Cholecystokinin A agonist
0,038  0,014  Cholesterol ester transfer protein antagonist
0,029  0,006  GABA transporter inhibitor
0,106  0,083  Antiprotozoal (Babesia)
0,221  0,198  CYP2C9 inhibitor
0,060  0,037  Botulinum neurotoxin type A inhibitor
0,032  0,009  Retinoic acid receptor agonist
0,034  0,011  LFA antagonist
0,106  0,083  Autism spectrum disorders treatment
0,065  0,042  HIV-1 integrase (3'-Processing) inhibitor
0,026  0,004  Telomerase stimulant
0,027  0,004  Angiotensin AT1B receptor antagonist
0,046  0,024  Nerve growth factor antagonist
0,050  0,028  Neurotensin receptor antagonist
0,051  0,028  Carnitine palmitoyltransferase 1B inhibitor
0,026  0,005  Excitatory amino acid transporter 1 inhibitor
0,045  0,023  Plasmepsin II inhibitor
0,079  0,058  Adrenaline agonist
0,056  0,035  Epithelial sodium channel blocker
0,030  0,009  Elastase 2 inhibitor
0,030  0,009  Elastase 2A inhibitor
0,026  0,006  Toll-Like receptor 8 agonist
0,053  0,032  CXC chemokine 1 receptor antagonist
0,028  0,008  Monocarboxylic acid transporter 1 inhibitor
0,028  0,008  Monocarboxylic acid transporter inhibitor
0,025  0,005  Vesicular glutamate transport inhibitor
0,030  0,009  Acid ceramidase inhibitor
0,060  0,040  Cathepsin E inhibitor
0,032  0,012  Estrogen-related receptor gamma antagonist
0,049  0,030  Aldosterone antagonist
0,028  0,008  Retinoic acid gamma receptor agonist
0,037  0,018  Adenosine uptake inhibitor
0,052  0,032  Potassium channel (Inward rectifier) activator
0,024  0,005  Thyroid hormone alpha agonist
0,022  0,002  Folate transporter 1 inhibitor
0,024  0,005  Nicotinic acid receptor 1 antagonist
0,044  0,025  Neurokinin 2 agonist
0,038  0,020  RNA-directed RNA polymerase inhibitor
0,022  0,004  Integrin beta6 antagonist
0,049  0,031  Potassium channel (ATP-sensitive) activator
0,028  0,010  Fructose-1,6-bisphosphatase 1 inhibitor
0,031  0,014  Protocollagen prolyl hydroxylase inhibitor
0,103  0,086  Neutropenia treatment
0,027  0,010  Integrin alpha4beta7 antagonist
0,066  0,049  Potassium channel large-conductance Ca-activated activator
0,073  0,056  CYP2A6 inhibitor
0,041  0,024  Glutamate (mGluR group II) antagonist
0,073  0,057  Nicotinic alpha4beta2 receptor antagonist
0,080  0,064  T cell inhibitor
0,025  0,009  Angiotensin AT1A receptor antagonist
0,048  0,032  Potassium channel Kv1.3 blocker
0,020  0,004  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,022  0,007  Antibiotic Anthracycline-like
0,125  0,110  Neuropeptide Y1 antagonist
0,035  0,020  HCV polyprotein inhibitor
0,037  0,023  Nicotinic acid receptor 2 agonist
0,102  0,088  Acetylcholine muscarinic antagonist
0,038  0,024  Delayed rectifier potassium channel blocker
0,048  0,034  Aminopeptidase N inhibitor
0,030  0,016  NMDA 2D receptor antagonist
0,020  0,007  Purinergic P2Y1 agonist
0,022  0,008  Estrogen-related receptor gamma agonist
0,029  0,015  Glucosylceramidase stimulant
0,040  0,027  Aggrecanase 1 inhibitor
0,038  0,025  Factor XIIIa inhibitor
0,045  0,032  Beta adrenoreceptor agonist
0,018  0,006  GABA transporter 1 inhibitor
0,037  0,025  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,028  0,016  Calcium-sensing receptor agonist
0,024  0,013  Endothelin A receptor antagonist
0,027  0,016  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,044  0,033  Phosphate transporter inhibitor
0,015  0,005  Carboxypeptidase B2 inhibitor
0,033  0,023  Melatonin receptor 1A agonist
0,017  0,007  Integrin alphaVbeta6 antagonist
0,014  0,004  Thyroid hormone beta agonist
0,087  0,077  Antithrombocytopenic
0,021  0,012  Endothelin B receptor antagonist
0,041  0,032  Histamine H2 receptor agonist
0,036  0,026  Histone deacetylase 7 inhibitor
0,028  0,018  Baculoviral IAP repeat-containing protein 4 inhibitor
0,051  0,042  GABA receptor antagonist
0,091  0,082  Estrogen receptor beta antagonist
0,037  0,028  DNA gyrase subunit B inhibitor
0,047  0,039  Collagenase inhibitor
0,012  0,003  Phosphoribosylglycinamide formyltransferase inhibitor
0,019  0,010  Integrin alpha4beta1 antagonist
0,028  0,020  1,3-Beta-glucan synthase inhibitor
0,021  0,013  Retinoic acid alpha receptor antagonist
0,011  0,003  Integrin alpha5beta6 antagonist
0,029  0,021  Liver X receptor alpha antagonist
0,013  0,005  Angiotensin AT2 receptor agonist
0,021  0,014  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,019  0,012  Retinoic acid receptor antagonist
0,031  0,024  Sirtuin 2 inhibitor
0,016  0,009  Egl nine homolog 1 inhibitor
0,018  0,012  CXC chemokine 5 receptor antagonist
0,034  0,027  Growth factor receptor-bound protein 2 antagonist
0,039  0,032  Liver X receptor alpha agonist
0,059  0,052  Phosphodiesterase 1C inhibitor
0,064  0,058  NMDA 2 receptor antagonist
0,041  0,034  Nicotinic receptor alpha3 subunit antagonist
0,012  0,006  Integrin alphaVbeta5 antagonist
0,020  0,014  Integrin beta7 antagonist
0,022  0,016  Vitamin D receptor antagonist
0,025  0,020  Integrin alpha2beta1 antagonist
0,078  0,073  Dyspepsia treatment
0,031  0,026  Liver X receptor beta agonist
0,029  0,024  Liver X receptor antagonist
0,035  0,030  Carbonic anhydrase I stimulant
0,029  0,024  HCV NS5B polymerase inhibitor
0,022  0,018  ICAM 1 antagonist
0,030  0,026  Dipeptidyl peptidase II inhibitor
0,025  0,021  Thymidine phosphorylase inhibitor
0,100  0,096  Cholinergic antagonist
0,042  0,038  Microtubule stabilization
0,049  0,044  Human rhinovirus A protease inhibitor
0,037  0,032  Histone deacetylase 9 inhibitor
0,025  0,021  Urotensin II agonist
0,008  0,005  Free fatty acid receptor 2 antagonist
0,056  0,053  Transcription factor AP-1 inhibitor
0,056  0,052  Narcolepsy treatment
0,024  0,021  Complement factor 1s inhibitor
0,064  0,061  Calcium channel L-type blocker
0,169  0,167  5 Hydroxytryptamine 1E antagonist
0,058  0,056  Histone deacetylase SIRT3 inhibitor
0,036  0,035  Glutamate (mGluR1a) antagonist
0,012  0,010  Antineoplastic (insulinoma)
0,014  0,012  Adenosine A2a receptor agonist
0,022  0,021  Sodium/glucose cotransporter 1 inhibitor
0,044  0,043  Matrix metalloproteinase 1 inhibitor
0,009  0,009  Excitatory amino acid transporter 4 inhibitor
0,005  0,004  Bone morphogenic protein 1 inhibitor
0,019  0,018  Corticosteroid-like
0,021  0,021  NMDA receptor glycine site antagonist
0,018  0,018  Antibiotic Quinolone-like

